select a format
Recent Viewed Reports
Why Ken Reasearch?
This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"
I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"
While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"
We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"
The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"
Cellmid Ltd (Cellmid), formerly Medical Therapies Limited develops therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products that include midkine ELISA kit, advangen international hair loss products and evolis products. Cellmid is developing three therapeutic programs such as AB102 oncology antibody, CAB101 inflammation antibody, and CMK103 cardiac ischemia. The company's products are used for the treatment and detection of cancers, the treatment of inflammatory, autoimmune diseases, and ischemic heart disease. It markets its products through its distributors in Australia and Japan. Cellmid is headquartered in Sydney, New South Wales, Australia.
Cellmid Ltd Key Recent Developments
Mar 02,2017: Cellmid's FGF5 Inhibitor Clinical Study Published
Jan 31,2017: Cellmid's USA Midkine Patent For Alopecia Allowed
Jan 18,2017: Cellmid Receives Australian Government Grant For Midkine Programme
Nov 03,2016: Cellmid: USA Launch of Evolis
Oct 10,2016: Cellmid Records Highest Ever Quarterly Sales For Evolis
This comprehensive SWOT profile of Cellmid Ltd provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cellmid Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1-About the Company
Cellmid Ltd-Key Information
Cellmid Ltd-Key Employees
Cellmid Ltd-Key Employee Biographies
Cellmid Ltd-Key Operational Heads
Cellmid Ltd-Major Products and Services
Cellmid Ltd-Company Statement
Cellmid Ltd-Locations And Subsidiaries
Cellmid Ltd-Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2-Company Analysis
Cellmid Ltd-Business Description
Cellmid Ltd-Corporate Strategy
Cellmid Ltd-SWOT Analysis
Cellmid Ltd-Key Competitors
Section 3-Company Financial Performance Charts
Cellmid Ltd-Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Note*: Some sections may be missing if data is unavailable for the company
List of Figures
Cellmid Ltd, Performance Chart
Cellmid Ltd, Ratio Charts
List of Tables
Cellmid Ltd, Key Information
Cellmid Ltd, Key Ratios
Cellmid Ltd, Share Data
Cellmid Ltd, Major Products and Services
Cellmid Ltd, History
Cellmid Ltd, Key Employees
Cellmid Ltd, Key Employee Biographies
Cellmid Ltd, Key Operational Heads
Cellmid Ltd, Other Locations
Cellmid Ltd, Subsidiaries
Cellmid Ltd, Key Manufacturing facilities
Cellmid Ltd, Key Competitors
Cellmid Ltd, SWOT Analysis
Cellmid Ltd, Ratios based on current share price
Cellmid Ltd, Annual Ratios
Cellmid Ltd, Interim Ratios
Capital Market Ratios
Single User License:
Corporate User License:
Cellmid Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts